Is Hims Hers Health Inc (HIMS) overvalued? · P/E 74, rev $1.48B
Hims Hers Health Inc (HIMS) is a household & personal products company listed on US.
This page asks whether Hims Hers Health Inc (HIMS) looks expensive on cached numbers — not a short thesis.
Latest reported HIMS revenue for 2024-12-31 was $1.48B. Net income was $126.0M. Revenue was up 69.3% from 2023-12-31 to 2024-12-31. HIMS currently screens at market cap $11.04B and trailing P/E 73.9.
HIMS currently screens at market cap $11.04B and trailing P/E 73.9. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next HIMS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the HIMS stock page for the full model, not this heading.
Not investment advice.